Skip to main navigation
Skip to search
Skip to main content
Arizona Board of Regents Home
Home
Profiles
Departments and Centers
Scholarly Works
Grants
Activities
Equipment
Datasets
Press/Media
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Pamela Marshall
Arizona State University
,
Mathematical and Natural Sciences, School of (SMNS)
Interim School Director & Professor
,
Arizona State University
,
Mathematical and Natural Sciences, School of (SMNS)
Email
Pamela.Marshall
asu
edu
h-index
693
Citations
14
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1989 …
2023
Research activity per year
Overview
Fingerprint
Network
Grants
(7)
Scholarly Works
(49)
Press/Media
(9)
Similar Profiles
(6)
If you made any changes in Pure these will be visible here soon.
Scholarly Works
Scholarly Works per year
1989
2007
2009
2011
2012
2013
2015
2019
2022
2023
36
Article
8
Patent
2
Review article
1
Comment/debate
2
More
1
Editorial
1
Letter
Scholarly Works per year
Scholarly Works per year
8 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Patent
Search results
2015
Novel Partial Retinoid X Receptor Agonists
Marshall, P.
&
Wagner, C.
,
Jan 12 2015
Research output
:
Patent
Bexarotene
100%
Retinoid X Receptors
83%
Alzheimer Disease
11%
Neurodegenerative Diseases
8%
Parkinson Disease
8%
Novel Partial Retinoid X Receptor Agonists -- additional compounds not disclosed in M15-137L
Marshall, P.
&
Wagner, C.
,
Mar 3 2015
Research output
:
Patent
Bexarotene
100%
galantide
86%
Retinoid X Receptors
83%
Alzheimer Disease
11%
Neurodegenerative Diseases
8%
2014
Compounds to Modulate RXR
Marshall, P.
&
Wagner, C.
,
Jan 8 2014
Research output
:
Patent
Bexarotene
100%
Retinoid X Receptors
83%
Alzheimer Disease
11%
Neurodegenerative Diseases
8%
Parkinson Disease
8%
2013
Addition of Parkinson's Disease to existing Patents
Marshall, P.
&
Wagner, C.
,
Oct 28 2013
Research output
:
Patent
Bexarotene
100%
Patents
74%
Retinoid X Receptors
55%
Parkinson Disease
51%
Alzheimer Disease
11%
2012
Therapeutic Compounds
Marshall, P.
&
Wagner, C.
,
Aug 17 2012
Research output
:
Patent
Bexarotene
100%
Retinoid X Receptors
55%
Alzheimer Disease
11%
Therapeutics
10%
Neurodegenerative Diseases
8%
2011
Novel Potential Retinoid X Receptor Agonists
Marshall, P.
&
Wagner, C.
,
Aug 24 2011
Research output
:
Patent
Bexarotene
100%
Retinoid X Receptors
83%
Alzheimer Disease
11%
Neurodegenerative Diseases
8%
Parkinson Disease
8%
Novel Potential Retinoid X Receptor Agonists 2
Marshall, P.
&
Wagner, C.
,
Dec 20 2011
Research output
:
Patent
Bexarotene
100%
Retinoid X Receptors
83%
Alzheimer Disease
17%
Inventors
12%
Cutaneous T-Cell Lymphoma
9%
2009
Potential Retinoid-X-Receptor Agonists: Novel Bexarotene Analogs
Marshall, P.
&
Wagner, C.
,
Jun 15 2009
Research output
:
Patent
Bexarotene
100%
Retinoid X Receptors
83%
Alzheimer Disease
11%
Neurodegenerative Diseases
8%
Parkinson Disease
8%